Peter A. Schwartz, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 6th Ave And Spruce St, W. Reading, PA 19611 Phone: 610-988-8827 Fax: 610-988-4242 |
News Archive
The New York Times reports that "the health care proposals from the House and the Senate are broadly similar but differ on some major issues." It reports on five issues - the public plan, employer contribution, abortion, illegal immigrants and financing - and puts differences in bold type (11/19).
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, despite potential safety concerns, Jazz Pharmaceuticals/UCB's sodium oxybate (JZP-6) will account for more than 15 percent of the fibromyalgia drug market in 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan. Sodium oxybate has demonstrated robust efficacy in Phase III clinical trials for fibromyalgia and interviewed thought leaders are impressed with its effect on several key symptom domains of fibromyalgia, which include pain, sleep and fatigue.
Capturing moving images of tiny protein molecules is the aim of a new research project announced today at Imperial College London. The research will reveal, on extremely short timescales, the miniscule movements of proteins which help carry out important biological processes in people, animals, insects and plants.
The antidepressant Cymbalta (duloxetine HCl), a dual-reuptake inhibitor of serotonin and norepinephrine, 60 mg once or twice daily, significantly reduced pain in more than half of women treated for fibromyalgia, with and without major depression, according to 12-week data presented at the annual meeting of the American College of Rheumatology.
Decoding the DNA of a woman who died of acute myeloid leukemia (AML) has led researchers at Washington University School of Medicine in St. Louis to a gene that they found to be commonly altered in many patients who died quickly of the disease.
› Verified 8 days ago